Skip to main content
Clinical Trials/ChiCTR2000039412
ChiCTR2000039412Active, not recruitingEarly Phase 1

微小 RNA-222 对于急性心肌梗死患者的诊断及预后评估价值研究

上海市卫生健康委员会1 site in 1 countryStarted: January 1, 2021Last updated:

Trial Snapshot

Phase
Early Phase 1
Status
Active, not recruiting
Sponsor
Locations
1
Primary Endpoint
SEN, SPE, ACC, AUC of ROC

Study Overview

Brief Summary

(1)探讨微小 RNA-222 在急性心肌梗死早期诊断中的作用; (2)探讨微小 RNA-222 对心肌梗死患者短期预后的评估作用; (3)通过比例风险模型,综合考虑传统危险因素、多种环状 RNA 表达水平,建立新型的心肌梗死后风险预估模型。

Study Design

Study Type
诊断试验
Primary Purpose
析因分组(即根据危险因素或暴露因素分组)
Masking
未说明

Eligibility Criteria

Ages
18 to 90 (—)
Sex
All

Inclusion Criteria

  • 2.急性心肌梗死发作患者;
  • 3.胸痛小于 12 小时。

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

SEN, SPE, ACC, AUC of ROC

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
上海市卫生健康委员会

Study Sites (1)

Loading locations...

Similar Trials